Navigation Links
Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
Date:5/16/2008

Nektar's Technology Enables First-Ever PEGylation of a Small Molecule with

Demonstrated Therapeutic Activity

SAN CARLOS, Calif., May 16 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced initial results today from a Phase 1 study of NKTR- 102, PEGylated irinotecan. The data shows significant anti-tumor activity in patients with refractory solid tumors. The study also demonstrates that Nektar's small molecule PEGylation technology produced an increase in SN38 exposure that was up to six-fold higher than the exposure previously reported with irinotecan at equivalent doses. SN38, a topoisomerase I inhibitor, is the active metabolite of irinotecan.

The ASCO abstract reports interim data on 27 of 32 patients in the first of three dose schedules from the Phase 1 trial.(1) Results for the first schedule (weekly x3 q4 weeks) found anti-tumor activity in 7 out of the total 32 patients evaluable for efficacy. Partial responses were confirmed in three patients, or 10% (greater than 30% tumor regression per RECIST), and other evidence of anti-tumor activity was confirmed in four patients, or 12% (tumor regression by more than 15% but less than 30% per RECIST, or significant biomarker evidence).

"This significant anti-tumor activity in a number of patients whose tumors have progressed on prior therapies makes NKTR-102 one of the most promising cancer drugs I have ever studied," said Daniel D. Von Hoff, M.D., lead Phase 1 investigator for NKTR-102, Physician-in-Chief at the Translational Genomics Research Institute and Chief Medical Officer for the Scottsdale Clinical Research Institute at Scottsdale Healthcare.

Nektar's proprietary PEGylation technology can enhance the properties of t
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 ... investing £2.5 million to help it meet the ... goods, healthcare, pharmaceuticals and logistics. Albion joins Shackleton ... ) Over the past 18 months ... its platform, its management team and its operations. ...
(Date:7/25/2014)... July 25, 2014  Depomed, Inc. (NASDAQ: ... quarter fiscal year 2014 financial results after the market ... a conference call beginning at 4:30 pm EDT, 1:30 pm PDT ... the call by dialing 877-317-6789 ( United States ... also be available via a live webcast on the ...
(Date:7/25/2014)... 2014 GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased ... ("MOU") with LaurelCo, LLC, an Illinois ... cultivation and dispensary medical marijuana licenses in the state of ... will acquire a 20% equity interest in LaurelCo, LLC in ... growing chambers, as well as all technology related to the ...
Breaking Medicine Technology:OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
... and LONDON, Nov. 20 Boston Scientific Corporation (NYSE: ... received 510(k) clearance from the U.S. Food and Drug ... WallFlex® Fully Covered Esophageal Stent for the treatment of ... with resectable or non-resectable esophageal cancer. , (Photo: ...
... , HOUSTON, Nov. 20 Cyberonics, Inc. (Nasdaq: CYBX ... and Greg Browne, Chief Financial Officer, will present at the 21st ... December 2, 2009 at 12:00 PM EST. The conference session ... be presented. Piper Jaffray will host a webcast of the ...
Cached Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:7/28/2014)... the years, many adolescents have been forced to accept ... in their knees. A new PhD study involving 3,000 ... carries on: , "We can see from the study ... of 12 and 19 experience problems with pain in ... knee pain in the front of the knee," says ...
(Date:7/28/2014)... at North Carolina State University is proposing a new ... ability with age, but don,t necessarily show declines in ... be how motivated older adults are to maintain focus ... wanted to explain the difference we see in cognitive ... professor of psychology at NC State and author of ...
(Date:7/28/2014)... July 28, 2014A group of researchers in Taiwan has ... to detect an early complication of diabetes sooner, when ... safe and effective in clinical trials, it may pave ... treatment of this complication, called diabetic autonomic neuropathy, which ... Type 2 diabetes. The condition progressively affects the autonomic ...
(Date:7/28/2014)... of Bradford, UK, have devised a simple blood ... have cancer or not. , The test ... presenting with certain symptoms, saving time and preventing costly ... being carried out. Alternatively, it could be a useful ... a cancer that is currently hard to diagnose. ...
(Date:7/28/2014)... the European project SOPHIE has evaluated the relationship ... inequalities in health in Europe. The results show ... southern Europe) and countries with contradictory policies (Eastern ... women reported poorer health than men. Health inequalities ... women present a 27% higher risk of having ...
Breaking Medicine News(10 mins):Health News:Many people never grow out of their growing pains 2Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Potential 'universal' blood test for cancer discovered 2Health News:Potential 'universal' blood test for cancer discovered 3Health News:Gender inequalities in health: A matter of policies 2
... Patients believe,that access to their prescription medications ... by unfair reimbursement practices and,policies to their community ... polling company(TM), inc., "Our patients have it ... in their health care," said Stephen Giroux, PD, ...
... Study finds false positives occur 9.2% of the time in ... doctors in the emergency room believe that someone is having ... time, a new study indicates. , Given that minutes matter ... in this setting, that percentage is tolerable, say researchers from ...
... An international team of researchers led by Mayo Clinic have ... a virus to destroy cancer cells that spread from primary ... system. In addition, their study shows that this technology could ... cancer recurrence. , The study appeared in the Dec. 9 ...
... for patients with spinal cord injuries can stimulate ... compensatory changes in the brain, say Canadian researchers. ... function and the ability to walk. , A ... the remarkable benefits of rehabilitation training after a ...
... Island Hospital has received a renewal of a $1.5 million ... examine the driving abilities of elderly drivers. The study is ... elders in their natural driving environments. , Under the ... Alzheimers Disease and Memory Disorders Center at Rhode Island Hospital, ...
... of North America 93rd ... Scientific Assembly and Annual Meeting, NEWPORT NEWS, Va., Dec. ... North America 93rd Scientific,Assembly and Annual Meeting demonstrated the value ... to mammography and,breast ultrasound. The study, performed by Dr. Jean ...
Cached Medicine News:Health News:Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs 2Health News:Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs 3Health News:Diagnosis of Heart Attack Can Be Wrong 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Intensive training post-spinal cord injury can stimulate repair in brain and spinal cord 2Health News:Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 2Health News:Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 3
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Ad-Techs Intraoperative Electrodes share ... electrodes. The main difference is ... discs are numbered to assist ... electrodes are designed for use ...
... the Selenia full field digital mammography ... new era in the world of ... innovation combines the latest advances in ... management capabilities to bring you the ...
... The P3000 heralds a new concept in ... binocular infrared optical system developed for the P2000. ... standard in which we have paid particular attention ... Our new system is extremely flexible, allowing ...
Medicine Products: